AMTX - CIK 0000738214
AEMETIS, INC trades as AMTX. In its fiscal 2025 annual report the company posted revenue of $197.63M, down 26.2% from the prior year and net income of -$77.00M. This page tracks AEMETIS, INC through 851 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years AEMETIS, INC's revenue grew from $143.16M to $197.63M, a compound annual growth rate of 3.6%. Net profit margin compressed from -10.9% to -39.0% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-26 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| Proxy statement | DEF 14A | 2026-04-07 |
| Insider trade | 4 | 2026-03-23 |
| Insider trade | 4 | 2026-03-23 |
| Insider trade | 4 | 2026-03-23 |
| Insider trade | 4 | 2026-03-23 |
The largest companies sharing AEMETIS, INC's SEC industry classification (industrial organic chemicals).
AEMETIS, INC reported revenue of $197.63M for fiscal year 2025, a decrease of 26.2% year over year.
In its latest fiscal year AEMETIS, INC reported a net loss of $77.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.